Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

European Lung Cancer Congress 2023

29 Mar - 01 Apr 2023

Copenhagen, Denmark

ESMO-ELCC-2023-1000x1000

Presentations (slides) and webcasts are available to ESMO Members and registered delegates according to the presenters' agreement to release them. 
Abstracts and ePosters are open access.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

Meeting programme Next/upcoming meetings
Review the current state-of-the-art in lung cancer therapy, update your knowledge in prevention, screening, detection and much more.

The European Lung Cancer Congress 2023 provides insights into the prevention, diagnosis, biology and multi-disciplinary management of thoracic malignancies. Learning objectives include updating knowledge in early detection, reviewing current state-of-the-art systemic management, and reviewing the emerging contribution of precision medicine, genomics technologies and artificial intelligence.

All resources are published!

You may use the filters or type the abstract number or any terms in the search box.

ESMO Colloquium supported by Eli Lilly & Company

Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage

Watch the webcasts

Industry partners' Satellite Symposia

Watch the webcasts

Hide
Filter by:
Search:
Reset

There are 410 resources available

Second vote and conclusions

Presenter: Corinne Faivre-Finn

Session: Stereotactic RT vs surgery in early stage NCSLC

Resources:

Slides

Webcast

Q&A

Presenter: Solange Peters

Session: ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage

Resources:

Webcast

Q&A

Presenter: Zofia Piotrowska

Session: Resistance after IO and targeted therapies: Patterns of emergence and management

Resources:

Webcast

Concluding remarks

Presenter: Benjamin Besse

Session: ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage

Resources:

Webcast

Introduction and first vote

Presenter: Lizza Hendriks

Session: Is neoadjuvant chemo-immunotherapy superior to adjuvant immunotherapy?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.